Psoriatic arthritis - what the dermatologist needs to know

被引：20

作者：

Laws, P. ^{[1
]}

Barton, A. ^{[2
]}

Warren, R. B. ^{[1
]}

机构：

[1] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester M13 9PT, Lancs, England

[2] Univ Manchester, Arc EU, Manchester M13 9PT, Lancs, England

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2010年 / 24卷 / 11期

关键词：

psoriasis; psoriatic arthritis; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; EFFICACY; PLACEBO; DISEASE; SAFETY; RISK; METHOTREXATE; ADALIMUMAB;

D O I：

10.1111/j.1468-3083.2010.03654.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Psoriasis is commonly associated with a co-existent arthritis known as psoriatic arthritis (PsA). Although there is some treatment overlap for psoriasis and psoriatic arthritis, it is possible that dermatologists may not diagnose or treat appropriately patients who are developing psoriatic arthritis at an early stage of the disease process when joint damage may be preventable. In this article we review the criteria for diagnosis of this sero-negative arthritis, look at the clinical indications for referral to a rheumatologist and discuss evolving treatment options relevant to both conditions.

引用

页码：1270 / 1277

页数：8

共 60 条

[1] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial [J].

Antoni, C ;

Krueger, GG ;

de Vlam, K ;

Birbara, C ;

Beutler, A ;

Guzzo, C ;

Zhou, B ;

Dooley, LT ;

Kavanaugh, A .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1150-1157

[2] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [J].

Antoni, CE ;

Kavanagh, A ;

Kirkham, B ;

Tutuncu, Z ;

Burmester, GR ;

Schneider, U ;

Furst, DE ;

Molitor, J ;

Keystone, E ;

Gladman, D ;

Manger, B ;

Wassenberg, S ;

Weier, R ;

Wallace, DJ ;

Weisman, MH ;

Kalden, JR ;

Smolen, J .

ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1227-1236

[3] The prevalence of sacroiliitis in psoriatic arthritis: new perspectives from a large, multicenter cohort - A Department of Veterans Affairs Cooperative Study [J].

Battistone, MJ ;

Manaster, BJ ;

Reda, DJ ;

Clegg, DO .

SKELETAL RADIOLOGY, 1999, 28 (04) :196-201

[4]

Belzunegui J, 2001, CLIN EXP RHEUMATOL, V19, P727

[5] Dactylitis in psoriatic arthritis: a marker for disease severity? [J].

Brockbank, JE ;

Stein, M ;

Schentag, CT ;

Gladman, DD .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :188-190

[6]

BUSKILA D, 1992, J RHEUMATOL, V19, P1115

[7] Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis [J].

Chalmers, RJG ;

Kirby, B ;

Smith, A ;

Burrows, P ;

Little, R ;

Horan, M ;

Hextall, JM ;

Smith, CH ;

Klaber, M ;

Rogers, S .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) :444-450

[8]

Chandran V, 2008, J RHEUMATOL, V35, P469

[9] International Multicenter Psoriasis and Psoriatic Arthritis Reliability Trial for the Assessment of Skin, Joints, Nails, and Dactylitis [J].

Chandran, Vinod ;

Gottlieb, Alice ;

Cook, Richard J. ;

Duffin, Kristina Callis ;

Garg, Amit ;

Helliwell, Philip ;

Kavanaugh, Arthur ;

Krueger, Gerald G. ;

Langley, Richard G. ;

Lynde, Charles ;

McHugh, Neil ;

Mease, Philip ;

Olivieri, Ignazio ;

Rahman, Proton ;

Rosen, Cheryl F. ;

Salvarani, Carlo ;

Thaci, Diamant ;

Toloza, Sergio M. A. ;

Wong, Maxine Yat Wing ;

Zhou, Qian M. ;

Gladman, Dafna D. .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09) :1235-1242

[10] Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial [J].

Choy, EHS ;

Hazleman, B ;

Smith, M ;

Moss, K ;

Lisi, L ;

Scott, DGI ;

Patel, J ;

Sopwith, M ;

Isenberg, DA .

RHEUMATOLOGY, 2002, 41 (10) :1133-1137

← 1 2 3 4 5 6 →